Trending...
- Lineus Medical Completes UK Registration for SafeBreak® Vascular
- Indies United is pleased to present our January 2026 book releases
- Chicago Man, 45, is Allegedly Caught on Camera Breaking Into a West Pullman Home on New Year's Day
Download
CHICAGO--(BUSINESS WIRE)--Researchers from Veradigm®, a leading provider of healthcare data and technology solutions, will present health economics and outcomes research (HEOR) data on Covid-19, diabetes, NASH (Non-Alcoholic Steatohepatitis), and cardiovascular disease at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Washington, D.C. from May 15-18, 2022.
"Accessing real-world data from across a variety of sources provides rich evidence for better decision-making and improved clinical outcomes for patients," said Tom Langan, Allscripts President and Chief Commercial Officer. "We're pleased to demonstrate how Veradigm provides tools that contribute to public health initiatives, like the Covid-19 Dashboard guiding outreach to underserved communities, or identifying risk factors with research that supports patients diagnosed with NASH earlier in their diagnosis or treatment."
Key data presentations at ISPOR 2022 include:
Covid-19
Real-World Data Dashboard Integrating Public Health & EHR Data for Identifying COVID-19 Vaccination Gaps in the US. L. Kallenbach. CODE: EPH60. May 17th 9:45 AM – 1:15 PM EDT.
SARS-COV-2 Vaccine Breakthrough Infection Rates Based Data from 3 EHRS. J. Overcash. CODE: RWD72. May 17th 9:45 AM – 1:15 PM EDT.
More on illi News
NASH
Assessing Cardiovascular Disease (CVD) Risk By Fibrosis Stage Defined By Fibrosis-4 (FIB-4) Among Patients with Non-Alcoholic Steatohepatitis (NASH) Using Real World Data (RWD). A. Bogdanov. CODE: EPH141. May 18th 9:00 AM – 12:45 PM EDT.
Comparing Fibrosis Staging Approaches Among Patients with Non-Alcoholic Steatohepatitis (NASH) Using Real World Data (RWD). A. Bogdanov. CODE: EPH161. May 16th 3:00 – 6:30 PM EDT.
Diabetes
Comparing Techniques for Mining HBA1C Data in Ambulatory EHRS for Use in RWE Research. N. Nguyen. CODE: RWD52. May 16th 3:00 - 6:30 PM EDT.
Artificial Intelligence (AI)
Categorizing Telemedicine Visits Using Natural Language Processing and Machine Learning. T. Sudaria. CODE: RWD112. May 17th 3:00 - 6:30 PM EDT.
Evaluating a Privacy Preserving Record Linkage (PPRL) Solution to Link De-identified Patient Records in RWD Using Default Matching Methods and Machine Learning Methods. N. Nguyen. CODE: RWD103. May 17th 3:00 - 6:30 PM EDT.
Additional presentations at ISPOR include Veradigm's Comparing Registry and Electronic Health Record (EHR) Data for Real-World Evidence Generation: Heart Failure as a Case Study (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ispor.org%2Fheor-resources%2Fpresentations-database%2Fpresentation%2Fintl2022-3489%2F14151&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=Comparing+Registry+and+Electronic+Health+Record+%28EHR%29+Data+for+Real-World+Evidence+Generation%3A+Heart+Failure+as+a+Case+Study&index=8&md5=44147095a4667c3af4af470e212a4b5c) on Tuesday, May 17 at 12:45 p.m. EDT. This presentation examines how generating real-world evidence (RWE) from heart failure patients requires clinical data elements not commonly found in administrative databases and has the potential to further understanding in heart failure management. Data were compared and contrasted from two different data sources, Veradigm's PINNACLE® Registry, a large cardiovascular disease registry developed by the American College of Cardiology, with those identified in the Practice Fusion ambulatory electronic health record (EHR) database.
More on illi News
For more presentation information titles, please visit ISPOR 2022 (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ispor.org%2Fconferences-education%2Fconferences%2Fupcoming-conferences%2Fispor-2022&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=ISPOR+2022&index=9&md5=cdd4b8d795dfdba36c6e84bd0e720b00).
About Veradigm®
Veradigm® is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. Some healthcare technology companies deliver clinical data for biopharma and health plans, some help turn that data into insights, others serve healthcare providers directly by providing point-of-care clinical software and patient outreach platforms. Only Veradigm does it all. In combination with Veradigm's companies and solutions, the Veradigm Network features a dynamic community of companies providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.
For more information on Veradigm, visit www.veradigm.com (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.veradigm.com%2F&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=www.veradigm.com&index=10&md5=c9c7e881e7286bf61b7c9fce467f916f), or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.allscripts.com%2F&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=www.allscripts.com&index=11&md5=7936ac5e4218d8cae96733b8a669ab77), Twitter (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.twitter.com%2Fallscripts&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=Twitter&index=12&md5=a1383a286347cebcdcdd4485b2dcf603), YouTube (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.youtube.com%2FAllscriptsTV&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=YouTube&index=13&md5=9629ac2282994724aae38a500a0c7871) and It Takes A Community: The Allscripts Blog (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fblog.allscripts.com%2F&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=It+Takes+A+Community%3A+The+Allscripts+Blog&index=14&md5=e5405b3ef183a45268980cc13a20eb0a).
© 2022 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Contacts
Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@allscripts.com
Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com
0) { // Create container for hi-res image jQuery('#bw-release-hires').append('
'); }; }); ]]>
Contacts
Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@allscripts.com
Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com
CHICAGO--(BUSINESS WIRE)--Researchers from Veradigm®, a leading provider of healthcare data and technology solutions, will present health economics and outcomes research (HEOR) data on Covid-19, diabetes, NASH (Non-Alcoholic Steatohepatitis), and cardiovascular disease at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Washington, D.C. from May 15-18, 2022.
"Accessing real-world data from across a variety of sources provides rich evidence for better decision-making and improved clinical outcomes for patients," said Tom Langan, Allscripts President and Chief Commercial Officer. "We're pleased to demonstrate how Veradigm provides tools that contribute to public health initiatives, like the Covid-19 Dashboard guiding outreach to underserved communities, or identifying risk factors with research that supports patients diagnosed with NASH earlier in their diagnosis or treatment."
Key data presentations at ISPOR 2022 include:
Covid-19
Real-World Data Dashboard Integrating Public Health & EHR Data for Identifying COVID-19 Vaccination Gaps in the US. L. Kallenbach. CODE: EPH60. May 17th 9:45 AM – 1:15 PM EDT.
SARS-COV-2 Vaccine Breakthrough Infection Rates Based Data from 3 EHRS. J. Overcash. CODE: RWD72. May 17th 9:45 AM – 1:15 PM EDT.
More on illi News
- New Book and Guided Journal Encourage Healing Through Honest Communication
- Stout Industrial Technology Appoints Paul Bonnett as Chief Executive Officer
- Revenue Optics Appoints Ljupco Icevski as Executive Advisor in Strategic Move to Accelerate Commercial Development
- Waarom brand mentions in ChatGPT steeds belangrijker worden
- Yunishigawa Onsen's Annual "Kamakura Festival" will be held January 30 – March 1, 2026
NASH
Assessing Cardiovascular Disease (CVD) Risk By Fibrosis Stage Defined By Fibrosis-4 (FIB-4) Among Patients with Non-Alcoholic Steatohepatitis (NASH) Using Real World Data (RWD). A. Bogdanov. CODE: EPH141. May 18th 9:00 AM – 12:45 PM EDT.
Comparing Fibrosis Staging Approaches Among Patients with Non-Alcoholic Steatohepatitis (NASH) Using Real World Data (RWD). A. Bogdanov. CODE: EPH161. May 16th 3:00 – 6:30 PM EDT.
Diabetes
Comparing Techniques for Mining HBA1C Data in Ambulatory EHRS for Use in RWE Research. N. Nguyen. CODE: RWD52. May 16th 3:00 - 6:30 PM EDT.
Artificial Intelligence (AI)
Categorizing Telemedicine Visits Using Natural Language Processing and Machine Learning. T. Sudaria. CODE: RWD112. May 17th 3:00 - 6:30 PM EDT.
Evaluating a Privacy Preserving Record Linkage (PPRL) Solution to Link De-identified Patient Records in RWD Using Default Matching Methods and Machine Learning Methods. N. Nguyen. CODE: RWD103. May 17th 3:00 - 6:30 PM EDT.
Additional presentations at ISPOR include Veradigm's Comparing Registry and Electronic Health Record (EHR) Data for Real-World Evidence Generation: Heart Failure as a Case Study (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ispor.org%2Fheor-resources%2Fpresentations-database%2Fpresentation%2Fintl2022-3489%2F14151&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=Comparing+Registry+and+Electronic+Health+Record+%28EHR%29+Data+for+Real-World+Evidence+Generation%3A+Heart+Failure+as+a+Case+Study&index=8&md5=44147095a4667c3af4af470e212a4b5c) on Tuesday, May 17 at 12:45 p.m. EDT. This presentation examines how generating real-world evidence (RWE) from heart failure patients requires clinical data elements not commonly found in administrative databases and has the potential to further understanding in heart failure management. Data were compared and contrasted from two different data sources, Veradigm's PINNACLE® Registry, a large cardiovascular disease registry developed by the American College of Cardiology, with those identified in the Practice Fusion ambulatory electronic health record (EHR) database.
More on illi News
- At Your Service Plumbing Named a 2025 Nextdoor Neighborhood Fave
- Chicago: Mayor Brandon Johnson Breaks Ground On First 'Missing Middle' Housing Development in North Lawndale
- Custom Home Builder Connecticut Valley Homes Wins 2025 Home of the Year from the Modular Home Builders Association
- Scoop Social Co. Partners with Air Canada to Celebrate New Direct Flights to Milan with Custom Italian Piaggio Ape Gelato Carts
- Litera's Agentic AI Drives 10x User Growth in 3 Months since Launching
For more presentation information titles, please visit ISPOR 2022 (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ispor.org%2Fconferences-education%2Fconferences%2Fupcoming-conferences%2Fispor-2022&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=ISPOR+2022&index=9&md5=cdd4b8d795dfdba36c6e84bd0e720b00).
About Veradigm®
Veradigm® is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. Some healthcare technology companies deliver clinical data for biopharma and health plans, some help turn that data into insights, others serve healthcare providers directly by providing point-of-care clinical software and patient outreach platforms. Only Veradigm does it all. In combination with Veradigm's companies and solutions, the Veradigm Network features a dynamic community of companies providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.
For more information on Veradigm, visit www.veradigm.com (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.veradigm.com%2F&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=www.veradigm.com&index=10&md5=c9c7e881e7286bf61b7c9fce467f916f), or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.allscripts.com%2F&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=www.allscripts.com&index=11&md5=7936ac5e4218d8cae96733b8a669ab77), Twitter (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.twitter.com%2Fallscripts&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=Twitter&index=12&md5=a1383a286347cebcdcdd4485b2dcf603), YouTube (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.youtube.com%2FAllscriptsTV&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=YouTube&index=13&md5=9629ac2282994724aae38a500a0c7871) and It Takes A Community: The Allscripts Blog (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fblog.allscripts.com%2F&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=It+Takes+A+Community%3A+The+Allscripts+Blog&index=14&md5=e5405b3ef183a45268980cc13a20eb0a).
© 2022 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Contacts
Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@allscripts.com
Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com
0) { // Create container for hi-res image jQuery('#bw-release-hires').append('
'); }; }); ]]>
Contacts
Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@allscripts.com
Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com
Filed Under: Business
0 Comments
Latest on illi News
- Really Cool Music Releases Its Fourth Single - "So Many Lost Years"
- MGN Logistics Acquires Fast Service LLC, Fueling MyMGN Marketplace Expansion and Supercharging Expedited Coverage Nationwide
- The Wait is Over: Salida Wine Festival Announces Triumphant 2026 Return After Seven-Year Hiatus
- Graduates With $40K in Student Debt Are Buying Businesses Instead of Taking Entry-Level Jobs
- Anne Seidman: Within the Lines
- How Democrats Made Healthcare More Expensive in 2026
- Inkdnylon Launches Bilingual Ask Inkdnylon Platform
- JS Gallery Brings Global Voices to LA Art Show 2026 with "OFF SCRIPT" Exhibition
- Chicago Man, 45, is Allegedly Caught on Camera Breaking Into a West Pullman Home on New Year's Day
- ANTOANETTA Partners With Zestacor Digital Marketing to Expand Online Presence for Handcrafted Luxury Jewelry
- Digi 995 Launches as an Independent Digital Universe Powered by Community and Creator Vision
- Litchfield Cavo Announces Six Partners Elected for 2026
- FrostSkin Launches Kickstarter Campaign for Patent-Pending Instant-Chill Water Purification Bottle
- The New Monaco of the South (of Italy)
- Indies United is pleased to present our January 2026 book releases
- Lick Personal Oils Introduces the Ultimate Valentine's Day Gift Collection for Romantic, Thoughtful Gifting
- Unauthorized Charge Dispute Raises Abuse Concerns in North Riverside Loan Office
- EMERALDWISDOM Trading Center Establishes FinTech Research Initiative
- Lacy Hendricks Earns Prestigious MPM® Designation from NARPM®
- Walmart $WMT and COSTCO.COM $COST Distribution as SonicShieldX™ Platform Sets the Stage for Accelerated Growth in 2026: AXIL Brands (N Y S E: AXIL)